MIRA advances Ketamir-2 in the clinic for neuropathic pain while broadening development into neuropsychiatric disorders such ...

Minors are vulnerable to harmful or offensive content, cyberbullying, and poorly regulated online marketing. In response, ...

Xencor remains a 'Strong Buy' in my view despite the stock's 60% performance decline. Click here to find out why XNCR stock ...

The implementation of the EU's Digital Services Act in Serbia and other countries lacking an independent digital services ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...

New Content Signals Policy will empower website owners to declare preferences on how AI companies access and use their ...

Beta version of PredicTcell™ expands training dataset to ~1.4 million and total dataset to over 6.7 billion records. Potential future T cell therapies could reliably bind to their target nearly every ...

The causal biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD) and their clinical value remain unclear. In this study, we ...

Security end-users tend to approach hardware-based solutions like key cabinets and asset management lockers as singular ...

Users are turning to the platform for instant answers, how-to advice, and writing help. Non-work-related messages are up 53% ...

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with ...

Inmazeb ® (atoltivimab, maftivimab, and odesivimab-ebgn) was the first treatment approved by the U.S. Food and Drug Administration (FDA) for ...